insights_auto
Why is TCRX down 3.55%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
$0.15
arrow_downward
-3.55%(-0.0057) 1D
Nov 16, 2:25:25 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
$0.16
High
$0.17
Low
$0.15
Mkt. cap
10.54M
Avg. vol.
549.53K
Volume
295.26K
52-wk high
$1.47
52-wk low
$0.15
EPS
-$0.89
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
Open
$0.16
High
$0.17
Low
$0.15
Mkt. cap
10.54M
Avg. vol.
549.53K
Volume
295.26K
52-wk high
$1.47
52-wk low
$0.15
EPS
-$0.89
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
News stories
From web sources and news partners
Investor's Business Daily
·
22 minutes ago
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
The Motley Fool
·
1 hour ago
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Yahoo Finance
·
14 minutes ago
The S&P 500’s shot at 4 straight double-digit years is in Nvidia’s hands
The Korea Times
·
1 hour ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitetscan.com